What should be the primary target of "treat to target" in psoriatic arthritis?
<h4>Background</h4> <p>Treat to Target in psoriatic arthritis (PsA) recommendations have stated that the target should be remission or inactive disease. Potential definitions include Very Low Disease Activity (VLDA), PsA Disease Activity Score (PASDAS) near remission, Disease Act...
Հիմնական հեղինակներ: | Coates, LC, Lubrano, E, Perrotta, FM, Emery, P, Conaghan, PG, Helliwell, PS |
---|---|
Ձևաչափ: | Journal article |
Լեզու: | English |
Հրապարակվել է: |
Journal of Rheumatology
2018
|
Նմանատիպ նյութեր
-
What should be the primary target of ‘treat to target’ in PsA?
: Coates, L, և այլն
Հրապարակվել է: (2018) -
Treat-to-target in psoriatic arthritis—cost-effective in the biosimilar era
: Coates, L, և այլն
Հրապարակվել է: (2022) -
Long-term follow-up of patients in the TIght COntrol of inflammation in early Psoriatic Arthritis (TICOPA) trial
: Coates, L, և այլն
Հրապարակվել է: (2019) -
Sustained very low disease activity and remission in psoriatic arthritis patients
: Lubrano, E, և այլն
Հրապարակվել է: (2019) -
Secukinumab for ankylosing spondylitis and psoriatic arthritis
: Lubrano E, և այլն
Հրապարակվել է: (2016-10-01)